Optimizing Anti-IL17 Antibody Therapy by Associating Fiber Supplementation to Correct Treatment-aggravated Gut Dysbiosis in Axial Spondyloarthritis - RESPOND-IL17
NCT05812157
Ankylosis, Arthritis
Nîmes, Gard, France
View Trial DetailsNCT Number: NCT00726765
This is a multi-national, multi-site, observational study to determine which of two strategies, when used by referring physicians is superior in the diagnosis of axial spondyloarthritis (AS) by rheumatologists.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Subjects will be selected using a non-probability sampling method. For each center of excellence, the local network of referring physicians will be assigned, according to a random code in a 1:1 ratio, to use one of the two referral strategies for eligible patients.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Approximately 3-6 months
Time frame: Approximately 3-6 months
Time frame: Approximately 3-6 months
Time frame: Approximately 3-6 months
Merck Sharp & Dohme LLC
Industry
Observational Trial on the Value of Diagnostic Criteria in the Diagnosis of Spinal Spondyloarthropathies in Patients With Chronic Low Back Pain
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05812157
Ankylosis, Arthritis
Nîmes, Gard, France
View Trial DetailsNCT02374749
Ankylosis, Arthritis
Paris, France
View Trial DetailsNCT05006690
Ankylosing Spondylitis, Ankylosis
Ankara, Turkey (Türkiye)
View Trial DetailsNCT06072859
Ankylosis, Anxiety Disorders
Portland, Oregon, United States
View Trial Details